^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
Pancreasure

Company:
Immunovia
Type:
Laboratory Developed Test
Related tests:
Evidence

News

15d
Immunovia launches ASSURE registry to evaluate real-world clinical impact of PancreaSure in high-risk pancreatic cancer surveillance (Immunovia Press Release)
''Immunovia AB...today announced the launch of ASSURE, a post-marketing registry evaluating the real-world clinical impact of its commercially available blood-based biomarker test, PancreaSure. The study is designed to capture clinical data on how PancreaSure influences clinician decision-making in pancreatic cancer surveillance. Data generated in ASSURE will support Immunovia's reimbursement efforts and clinician adoption of the test.''
Launch
|
Pancreasure